Low Income Subsidy Eligibility and What It Covers in 2026
The Low Income Subsidy (LIS), often called Extra Help, provides financial support to Medicare beneficiaries who find prescription drug costs burdensome. With 2026 approaching, changes in who qualifies and what is covered are expected. It's worth knowing these updates to get the most out of the benefits.
Eligibility Criteria for 2026
Whether you qualify for LIS hinges on income and resource limits. The Centers for Medicare & Medicaid Services (CMS) revisits these limits regularly. Come 2026, individuals earning up to 150% of the federal poverty level (FPL) might be eligible. For context, this means around $20,700 per year for a single person or $27,900 for a married couple, based on 2023 numbers adjusted for inflation.
Assets also play a role in determining eligibility. The cap for countable resources is $15,000 for an individual or $30,000 for a couple. This includes savings, investments, and real estate, but not your main home, personal items, or vehicles.
Benefits of the Low Income Subsidy
Those who qualify for LIS get help with premiums, deductibles, and co-payments. Full subsidy recipients in 2026 will have premiums fully covered for benchmark plans. Those who qualify for a partial subsidy will see reductions on a sliding scale.
, full subsidy beneficiaries will find deductibles reduced or even eliminated. Co-payments for generic and brand-name drugs are kept in check. In 2026, the most you might pay for a generic drug is expected to be $4.15, while brand-name drugs could cost up to $10.35, reflecting minor increases as federal guidelines adjust.
Coverage Specifics
LIS provides coverage for a wide range of medications, including generics, brands, and specialty drugs. Take Humira (adalimumab) by AbbVie, for example. Though it's often in higher tiers due to its price, LIS makes it more affordable. Beneficiaries can enjoy lower co-payments for such costly medications, easing access to necessary treatments.
The tier a drug is placed in affects coverage levels. Most Medicare Part D plans sort drugs into tiers. Generic drugs are usually in Tier 1 and are the cheapest. Brand-name drugs like Eliquis (apixaban) by Bristol-Myers Squibb often land in Tier 3, carrying higher costs. With LIS, even these pricier drugs become much more affordable.
Policy Changes Effective in 2026
In 2026, an important policy shift will occur. The Inflation Reduction Act of 2022 set an annual out-of-pocket expense cap at $2,000 for all Medicare Part D beneficiaries. This cap is a for those with hefty prescription drug costs, offering extra relief for LIS beneficiaries.
Additionally, the Act requires Medicare to negotiate drug prices, which is expected to reduce costs for certain high-expense drugs. These changes aim to lessen the financial strain on beneficiaries who need expensive medications, further boosting LIS benefits.
How to Apply for the Low Income Subsidy
To apply for LIS, you should reach out to the Social Security Administration (SSA). Applications are welcome online, by phone, or in person. The SSA evaluates eligibility based on income, resources, and household size.
If you're a Medicare beneficiary already receiving Medicaid or Supplemental Security Income (SSI), you're automatically eligible for LIS. You should receive notifications confirming your status and any steps needed to maintain your benefits.
Conclusion
It's to understand LIS eligibility and benefits if you need help with prescription drug costs. As 2026 draws near, keeping up with policy changes and how they affect coverage is important. Check your status each year to make sure you’re getting all the help you qualify for.
For more specific details on eligibility and benefits, consult the official CMS guidelines or talk to a healthcare insurance advisor.
Disclaimer: This article is for informational purposes only and does not constitute medical or insurance advice. Always consult with a professional for specific guidance tailored to your circumstances.